Companies / Vincerx Pharma, Inc.
Vincerx Pharma, Inc.
VINCCIK 1796129
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jun 29, 2021 | McDonald Andrew I Director | Buy Open-market buy | Common Stock | $247.6K | +20K | 20,000 | medium |
| Jun 29, 2021 | Seelenberger Alexander A. Executive | Buy Open-market buy | Common Stock | $100.3K | +8K | 7,950 | medium |
| Jun 29, 2021 | Hamdy Ahmed MD CEO | Buy Open-market buy | Common Stock | $100.0K | +8K | 7,830 | medium |
| Jun 29, 2021 | Lowe Christopher P. Director | Buy Open-market buy | Common Stock | $80.6K | +6K | 6,400 | medium |
| Dec 22, 2021 | Hamdy Ahmed MD CEO | Buy Open-market buy | Common Stock | $64.6K | +6K +82.38% | 14,280 | medium |
| Jun 27, 2022 | Izumi Raquel E. Executive | Buy Open-market buy | Common Stock | $56.3K | +40K | 40,000 | medium |
| Jun 30, 2021 | Lowe Christopher P. Director | Buy Open-market buy | Common Stock | $45.6K | +4K +56.25% | 10,000 | low |
| Jun 23, 2022 | Hamdy Ahmed MD CEO | Buy Open-market buy | Common Stock | $34.1K | +24K +169.47% | 38,480 | low |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| VINC | common | 92731L106 |
| VINC | common | 92731L304 |